CPF (L/min), N = 214 | p | SCSS, N = 208 | p | |||||
---|---|---|---|---|---|---|---|---|
< 60 N = 92 | N = 85 | > 90 N = 37 | 0–1 N = 26 | 2–3 N = 102 | 4–5 N = 80 | |||
Age, years | 76 ± 8 | 72 ± 9 | 68 ± 11 | < 0.01 | 81 ± 7 | 74 ± 8 | 69 ± 10 | < 0.01 |
Male | 64 (70%) | 73 (86%) | 35 (95%) | < 0.01 | 19 (73%) | 78 (77%) | 70 (88%) | 0.11 |
Charlson comorbidity index | 2 (1–3) | 1 (1–2) | 1 (0–2) | 0.02 | 2 (1–3) | 2 (1–2) | 1 (1–2) | < 0.01 |
Weaning category | ||||||||
Simple weaning | 47 (51%) | 62 (73%) | 28 (76%) | 0.02 | 11 (42%) | 61 (60%) | 59 (74%) | < 0.01 |
Difficult weaning | 37 (40%) | 20 (24%) | 8 (22%) | 10 (39%) | 37 (36%) | 18 (23%) | ||
Prolonged weaning | 8 (9%) | 3 (4%) | 1 (3%) | 5 (19%) | 4 (4%) | 3 (4%) | ||
Variables collected before extubation | ||||||||
Duration of MV before extubation, d | 6 (4–9) | 5 (3–6) | 5 (3–7) | 0.04 | 8 (6–10) | 5 (3–8) | 4 (3–6) | < 0.01 |
PEEP, cmH2O | 5 (4–6) | 5 (4–6) | 5 (4–5) | 0.44 | 5 (5–6) | 5 (4–6) | 5 (4–5) | 0.10 |
APACHE II score | 13 ± 3 | 12 ± 3 | 11 ± 3 | < 0.01 | 14 ± 3 | 13 ± 3 | 11 ± 3 | < 0.01 |
Hemoglobin, g/dl | 11.1 ± 2.2 | 12.0 ± 2.1 | 12.8 ± 2.0 | < 0.01 | 10.2 ± 2.1 | 11.6 ± 2.2 | 12.5 ± 2.1 | < 0.01 |
Albumin, g/L | 30 ± 4 | 31 ± 5 | 32 ± 5 | 0.04 | 30 ± 4 | 30 ± 4 | 31 ± 5 | 0.44 |
Respiratory rate, breaths/min | 22 ± 5 | 21 ± 5 | 22 ± 6 | 0.67 | 23 ± 5 | 21 ± 5 | 21 ± 5 | 0.35 |
Rapid shallow breathing index | 59 ± 25 | 51 ± 24 | 50 ± 24 | 0.06 | 61 ± 23 | 58 ± 26 | 49 ± 23 | 0.02 |
Heart rate, beats/min | 96 ± 16 | 99 ± 16 | 95 ± 13 | 0.23 | 96 ± 17 | 99 ± 15 | 96 ± 16 | 0.37 |
Systolic blood pressure, mmHg | 134 ± 22 | 135 ± 22 | 132 ± 22 | 0.74 | 133 ± 17 | 136 ± 24 | 132 ± 21 | 0.47 |
Diastolic blood pressure, mmHg | 70 ± 12 | 74 ± 12 | 73 ± 12 | 0.03 | 67 ± 10 | 73 ± 12 | 74 ± 12 | 0.03 |
PH | 7.42 ± 0.05 | 7.41 ± 0.05 | 7.42 ± 0.05 | 0.47 | 7.43 ± 0.06 | 7.41 ± 0.05 | 7.42 ± 0.05 | 0.41 |
PaCO2, mmHg | 54 ± 11 | 56 ± 11 | 51 ± 12 | 0.12 | 50 ± 12 | 56 ± 11 | 53 ± 12 | 0.02 |
PaO2/FiO2, mmHg | 232 ± 71 | 212 ± 55 | 212 ± 48 | 0.06 | 249 ± 67 | 223 ± 67 | 210 ± 50 | 0.02 |
Prophylactic use of NIV or HFNC | 68 (74%) | 70 (82%) | 20 (54%) | < 0.01 | 17 (65%) | 82 (80%) | 55 (69%) | 0.12 |
Reintubation at 72 h | 14 (15%) | 2 (2%) | 2 (5%) | < 0.01 | 7 (27%) | 6 (6%) | 4 (5%) | < 0.01 |
Duration of hospital stay, days | 21 (14–31) | 17 (12–26) | 17 (11 -22) | 0.04 | 21 (15–25) | 19 (13–28) | 17 (10–23) | 0.03 |
Duration of ICU stay, days | 14 (10–23) | 12 (7–16) | 9 (6–12) | < 0.01 | 14 (12–23) | 13 (8–22) | 9 (6–15) | < 0.01 |
Duration of hospital stay after extubation, days | 12 (7–18) | 11 (6–17) | 10 (6–13) | 0.21 | 9 (5–14) | 11 (8–19) | 10 (5–16) | 0.08 |
Duration of ICU stay after extubation, days | 7 (4–14) | 6 (3–9) | 4 (2–8) | < 0.01 | 7 (4–11) | 7 (5–11) | 5 (2–8) | < 0.01 |